A double blinded randomized trial comparing a new GM-CSF, LEUCOTROPIN™, and LEUCOMAX® for myeloid reconstitution following autologous peripheral blood stem cell transplantation (APBSCT).

被引：0
|
作者：
Sinclair, CJD
Bence-Bruckler, I
Turner, AR
Bredeson, C
Stewart, DA
Poynton, CH
Hatton, CSR
Couban, S
Howson-Jan, K
Marcus, R
Genereux, M
Ede, M
Stewart, DI
机构：
[1] Cangene Corp, Winnipeg, MB, Canada
[2] Univ Ottawa, Ottawa, ON K1N 6N5, Canada
[3] Univ Alberta, Edmonton, AB T6G 2M7, Canada
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[5] Univ Calgary, Calgary, AB T2N 1N4, Canada
[6] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales
[7] John Radcliffe Hosp, Oxford OX3 9DU, England
[8] Dalhousie Univ, Halifax, NS B3H 3J5, Canada
[9] Univ Western Ontario, London, ON N6A 3K7, Canada
[10] Addenbrookes Hosp, Cambridge, England
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3415
引用
收藏
页码：866A / 866A
页数：1
相关论文
共 50 条
  • [31] Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation
    C Colby
    SL McAfee
    DM Finkelstein
    TR Spitzer
    Bone Marrow Transplantation, 1998, 21 : 1005 - 1010
  • [32] Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma
    Bhatia, Smita
    Yan, Chengcheng
    Richard, Melissa A.
    He, Jianbo
    Bosworth, Alysia
    Crossman, David
    Singh, Purnima
    Hageman, Lindsey
    Armenian, Saro H.
    Vose, Julie M.
    Weisdorf, Daniel J.
    Yasui, Yutaka
    Ebert, Benjamin L.
    Gibson, Christopher J.
    Forman, Stephen J.
    Bhatia, Ravi
    BLOOD, 2022, 140
  • [33] PROMPT HEMATOPOIETIC RECONSTITUTION FOLLOWING HYPERTHERMIA PURGED AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN ACUTE MYELOID-LEUKEMIA
    HERRMANN, RP
    OREILLY, J
    MEYER, BF
    LAZZARO, G
    BONE MARROW TRANSPLANTATION, 1992, 10 (03) : 293 - 295
  • [34] Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: A randomized prospective study
    Gazitt, Y
    Callander, N
    Freytes, CO
    Shaughnessy, P
    Liu, Q
    Tsai, TW
    Devore, P
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (05): : 737 - 748
  • [35] Prospective randomized clinical trial comparing high-dose ifosfamide plus GM-CSF vs high-dose cyclophosphamide plus GM-CSF for blood progenitor cell mobilization
    Vela-Ojeda, J
    Tripp-Villanueva, F
    Montiel-Cervantes, L
    Sánchez-Cortés, E
    Ayala-Sánchez, M
    Guevara-Moreno, ME
    García-León, LD
    Rosas-Cabral, A
    Esparza, MAGR
    González-Llaven, J
    BONE MARROW TRANSPLANTATION, 2000, 25 (11) : 1141 - 1146
  • [36] Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation
    Schlenke, P
    Sheikhzadeh, S
    Weber, K
    Wagner, T
    Kirchner, H
    BONE MARROW TRANSPLANTATION, 2001, 28 (03) : 251 - 257
  • [37] Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation
    P Schlenke
    S Sheikhzadeh
    K Weber
    T Wagner
    H Kirchner
    Bone Marrow Transplantation, 2001, 28 : 251 - 257
  • [38] GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
    Ho, Vincent T.
    Kim, Haesook T.
    Brock, Jennifer
    Galinsky, Ilene
    Daley, Heather
    Reynolds, Carol
    Weber, Augustine
    Pozdnyakova, Olga
    Severgnini, Mariano
    Nikiforow, Sarah
    Cutler, Corey
    Koreth, John
    Alyea, Edwin P.
    Antin, Joseph H.
    Gooptu, Mahasweta
    Romee, Rizwan
    Shapiro, Roman
    Chen, Yi-Bin
    Rosenblatt, Jacalyn
    Avigan, David
    Hodi, F. Stephen
    Dranoff, Glenn
    Wu, Catherine J.
    Ritz, Jerome
    Soiffer, Robert J.
    BLOOD ADVANCES, 2022, 6 (07) : 2183 - 2194
  • [39] Delayed Administration of Filgrastim (G-CSF) Following Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) in Pediatric Patients Does Not Change Time to Neutrophil Engraftment and Reduces Use of G-CSF
    Pai, Vinita
    Fernandez, Soledad A.
    Laudick, Melissa
    Rosselet, Robin
    Termuhlen, Amanda
    PEDIATRIC BLOOD & CANCER, 2010, 54 (05) : 728 - 733
  • [40] Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).
    Berger, Elizabeth
    Seet, Christopher
    Parthasarathy, Mala
    Rodriguez, Tulio
    Smith, Scott E.
    Toor, Amir
    Lee, Mary
    Petrowsky, Cecilia
    Fox-Geiman, Mary
    Stiff, Patrick
    BLOOD, 2009, 114 (22) : 1250 - 1251
12345